The Description of Covid-19 Patients with Comorbidities at K.R.M.T Wongsonegoro General Hospital of Semarang


  • Ninggar Febriyani Universitas Ngudi Waluyo
  • Yunita Galih Yudanari Universitas Ngudi Waluyo


The description, Comorbidities, Patients with COVID-19


Corona virus disease (COVID-19), is the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and it causes substantial morbidity and mortality. Older age and the presence of diabeticum, hypertension, and overweight significantly increase the risk of hospitalization and death in COVID-19 patients. To find out the description of COVID-19 patients with co-morbidities at RSUD K.R.M.T Wongsonegoro Semarang The design of this research is descriptive. The populations in this study were COVID-19 patients with comorbidities with a sample of 1795 respondents taken using a purposive sampling technique. Data collection tools used is medical records. The data were analyzed using the frequency distribution formula and calculated using the SPSS data processing software COVID-19 patients with the most comorbidity were hypertension 50.8%, diabetes mellitus 44.6%, cardiovascular heart 4.0%, lung disease 0.3%, and obesity 0.3%. It is hoped that the community will always protect themselves from COVID-19, especially those who have comorbidities.


Download data is not yet available.


Albitar O, Ballouze R, Ooi J, Sheikh GS. (2020). Risk Factors for Mortality Among Covid-19 Patients [Internet]. J Diabetes Res Clin Pract.. [cited 4 Agustus 2021]. Available from: https://www.diabetesresearchclinicalpractice.c om/article/S0168-8227(20)30545.

Aqmaria NW, Risanti ED, Mahmudah INN, Jatmiko SW. (2021). Obesitas Sebagai Faktor Resiko Keparahan Pada COVID-19. The 13th University Research Colloqium

CDC. Coronavirus (COVID-19): symptoms of coronavirus.Centers for Disease Control and Prevention. 2020

Corrales-Medina VF, Musher DM, Shachkina S, Chirinos JA. (2013). Acute pneumonia and the cardiovascular system. Lancet;381: 496–505.

Li G, Deng Q, Feng J, Li F, Xiong N, He Q (2020). Clinical characteristics of diabetic patients with COVID-19. Journal of Diabetes Research. doi: 10.1155/-2020/165-2403.

Petrakis, D., Margină, D., Tsarouhas, K., Tekos, F., Stan, M., Nikitovic, D., ...&Tsatsakis, A. (2020). Obesity a risk factor for increased COVID 19 prevalence, severity and lethality.Molecular medicine reports, 22(1), 9-19.

Putri, Nikma. A., Putra, A. E., & Mariko, R. (2021). Hubungan Usia, Jenis Kelamin Dan Gejala Dengan Kejadian COVID-19 di Sumatera Barat. Majalah Kedokteran Andalas, 44(2), 104-111.

Schiffrin, E. L., Flack, J. M., Ito, S., Muntner, P., & Webb, R. C. (2020). Hypertension and COVID-19. American journal of hypertension, 33(5), 373-374.

Setiati, S., & Azwar, M. K. (2020). COVID-19 and Indonesia. Acta Medica Indonesiana, 52(1), 84-89.

Shang, L., Shao, M., Guo, Q., Shi, J., Zhao, Y., Xiaokereti, J., & Tang, B. (2020). Diabetes mellitus is associated with severe infection and mortality in patients with COVID-19: a systematic review and meta-analysis. Archives of medical research, 51(7), 700-709.

Velavan, T. P., & Meyer, C. G. (2020). The COVID‐19 epidemic. Tropical medicine & international health, 25(3), 278.

Wu, Z.; McGoogan, J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020, 323, 1239–1242. [CrossRef]

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical Course and Risk Factors for Mortality of Adult Inpatients With COVID19 in Wuhan, China: A Retrospective Cohort Study. Lancet. 2020; 395:1054–1062.




How to Cite

Febriyani, N. ., & Yudanari, Y. G. (2022). The Description of Covid-19 Patients with Comorbidities at K.R.M.T Wongsonegoro General Hospital of Semarang. Proceedings of Conference on Health Universitas Ngudi Waluyo, 1(1), 220–224. Retrieved from